Proactive news headlines including Cobre Ltd, Bellevue Gold, Cyclone Metals and Chimeric Therapeutics
Retrieved on:
Thursday, January 19, 2023
Hydrogen, Lithium, MVL, QML, FHE, SPP, Lithium Triangle, DSF Refractories & Minerals Ltd, EM, Research, Motion, ASX, Proactivity, ESG, C29, CLE, Mining, Sale, HRZ, PGE, Gold, Trafalgar, GH2, Security (finance), Rare-earth element
Click here
Key Points:
- Click here
Bellevue Gold Ltd (ASX:BGL) is one step closer to maiden production at its namesake WA gold play after its Mining Proposal and Mine Closure Plan was approved. - Click here
Cyclone Metals Ltd (ASX:CLE) has received firm commitments from institutional and sophisticated investors to raise $1.35 million through a placement of fully paid ordinary shares at an issue price of $0.0025 per share. - Click here
Chimeric Therapeutics Ltd (ASX:CHM) has dosed the first patient in its Phase 1B CHM 0201 + Vactosertib clinical trial. - Click here
Arovella Therapeutics Ltd (ASX:ALA) has completed a A$1.655 million placement to new and existing institutional and sophisticated investors.